Wright Medical: Surviving as a Mid-Sized Device Company
Executive Summary
As Wright Medical's success suggests, the key for mid-tier companies lies not so much in devising innovative sales and marketing programs for these new customers, but in product planning and portfolio design, crafting the right product line for a more cost-conscious customer, while tapping into those technologically innovative opportunities that still exist.
You may also be interested in...
Is Wright Medical Back on Track?
Wright Medical hasn’t enjoyed the smoothest ride over the past 15 years, a stretch that included a spin-out, debt problems, and a buyout, as well as an IPO. All the while, though, the company has proven to be an innovator in the large joints industries and now—under new CEO Gary Henley—it is establishing itself as a force in the extremities and biomaterials markets.
Amedica Takes On Tough Sell in Orthopedics
Amedica says its high-strength silicon nitride-based ceramic could be the answer to some of the more vexing problems in spine, hip and knee surgeries. But can this materials science expert become a real orthopedics company?
A White Knight for Bausch & Lomb
Bausch & Lomb was slogging forward after a difficult year-the company had been embroiled in a lengthy accounting investigation involving some of its foreign subsidiaries since the end of 2005 and in early 2006 it was compelled to recall its most profitable product-. In mid-May 2007 Bausch & Lomb was wrestling with a 3% decrease in annual sales, 344 product liability lawsuits, and an overhanging intellectual property case that could affect its fastest growing contact lens line, when up galloped white knight private equity firm Warburg Pincus, with a $4.5 billion offer to take the ophthalmic company private.